<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Althenayyan S</submitter><funding>King Abdullah International Medical Research Center</funding><pagination>135</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9861497</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>There is a pertinent need to develop prognostic biomarkers for practicing predictive, preventive and personalized medicine (PPPM) in colorectal cancer metastasis. The analysis of isoform expression data governed by alternative splicing provides a high-resolution picture of mRNAs in a defined condition. This information would not be available by studying gene expression changes alone. Hence, we utilized our prior data from an exon microarray and found &lt;i>ADAM12&lt;/i> and &lt;i>MUC4&lt;/i> to be strong biomarker candidates based on their alternative splicing scores and pattern. In this study, we characterized their isoform expression in a cell line model of metastatic colorectal cancer (SW480 &amp; SW620). These two genes were found to be good prognostic indicators in two cohorts from The Cancer Genome </pubmed_abstract><journal>Journal of personalized medicine</journal><pubmed_title>Alternatively Spliced Isoforms of &amp;lt;i&amp;gt;MUC4&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;ADAM12&amp;lt;/i&amp;gt; as Biomarkers for Colorectal Cancer Metastasis.</pubmed_title><pmcid>PMC9861497</pmcid><funding_grant_id>RC18/185</funding_grant_id><pubmed_authors>Althenayyan S</pubmed_authors><pubmed_authors>Alsagaby SA</pubmed_authors><pubmed_authors>Aziz MA</pubmed_authors><pubmed_authors>Alghanem B</pubmed_authors><pubmed_authors>AlAbdulrahman A</pubmed_authors><pubmed_authors>Alfahed A</pubmed_authors><pubmed_authors>AlMuhanna MH</pubmed_authors><pubmed_authors>Alasiri G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alternatively Spliced Isoforms of &amp;lt;i&amp;gt;MUC4&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;ADAM12&amp;lt;/i&amp;gt; as Biomarkers for Colorectal Cancer Metastasis.</name><description>There is a pertinent need to develop prognostic biomarkers for practicing predictive, preventive and personalized medicine (PPPM) in colorectal cancer metastasis. The analysis of isoform expression data governed by alternative splicing provides a high-resolution picture of mRNAs in a defined condition. This information would not be available by studying gene expression changes alone. Hence, we utilized our prior data from an exon microarray and found &lt;i>ADAM12&lt;/i> and &lt;i>MUC4&lt;/i> to be strong biomarker candidates based on their alternative splicing scores and pattern. In this study, we characterized their isoform expression in a cell line model of metastatic colorectal cancer (SW480 &amp; SW620). These two genes were found to be good prognostic indicators in two cohorts from The Cancer Genome </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-06-13T03:27:10.757Z</modification><creation>2024-11-19T16:24:27.2Z</creation></dates><accession>S-EPMC9861497</accession><cross_references><pubmed>36675796</pubmed><doi>10.3390/jpm13010135</doi></cross_references></HashMap>